SGMC Health Offers New Early-Stage Alzheimer’s Treatment
SGMC Health in Valdosta, Georgia, has begun offering lecanemab, an FDA-approved monoclonal antibody, to patients with early-stage Alzheimer’s disease, targeting amyloid-beta plaques to potentially sluggish cognitive decline by up to ... Read More